Close
ACHEMA MIDDLE EAST 2026

Europe LIMS Market Steered By Germany – Arizton Report

As per a report by Arizton, the European laboratory information management system- LIMS market share is all set to reach $912.47 million by 2028. It...

Assessing Q1 2023: Indian Pharma Industry Growing Rapidly

Pharmaceutical companies are turning their attention to the Indian market as revenues decline in the US, Europe, and emerging markets. Indian companies like Sun...

Cell & Gene Therapy CDMO Market – Steady Growth On The Cards

The cell and gene therapy CDMO services market happened to be valued at $5193.7 million last year and is now anticipated to grow at...

SVB Collapse And Its Implications On Biotechnology Sector

Within just 48 hours, the bank that several new biotechnology companies had relied on for ages was gone. On March 10, the Federal Deposit Insurance...

US President Looks To Double The Drugs For Price Negotiation

President Joe Biden is looking to double the number of medicines that Medicare can help negotiate rates for and thereby enable the government to...

$118bn Sales By 2026 Is What Japanese Pharma Can Expect

One of the most important trade fairs in the pharmaceutical industry will soon be taking place in Japan as it sees a huge resurgence...

Bioavailability Enhancement Market Projects CAGR of 11%

Since more biopharmaceutics classification system- BCS II as well as BCS IV molecules are being evaluated in the early stages of development, one of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...